Rosemont has over 50 years of expertise in the development, manufacture and distribution of oral liquid medicines for patients unable to swallow solid medications. At our state-of-the-art manufacturing site in the UK, we produce over 4 million bottles of liquid medicine every year. Our focus on research and development is the key to growth in our portfolio and we continuously invest in our facilities to ensure we have the latest technologies to enhance our capabilities and capacity. For more information about Rosemont Pharmaceuticals, please view our corporate brochure.
We look for opportunities to expand the reach of our liquid medicines into new countries and regions across the world and seek partners to work with on these projects. If you are interested in becoming a distributor for the Rosemont liquid medicine portfolio, please email firstname.lastname@example.org.
Rosemont also seek out licensing partnership opportunities to market medicines in the UK. We are keen to hear from manufacturers looking for a partner with expertise and a proven track record in commercialising product in the UK. In addition, if you require a specialist contract manufacturer of liquid medicines please contact email@example.com.
Rosemont products are exported worldwide, our portfolio is sold in more than 25 countries.
Rosemont Pharmaceuticals manufacture and supply over 130 oral liquid medicines covering most therapeutic categories. For more information about our liquid medicines, view our product pages or download the Rosemont app.
When developing products, we include only the minimal necessary excipients, to ensure suitability for patients with a variety of religious and dietary requirements. We aim to produce medicines which are suitable for diabetics and vegetarians. Other excipients such as glucose, lactose, sorbitol, fructose, gluten, aspartame, tartrazine, arachis oil and ethanol are avoided wherever possible. Low sodium levels are also a target. All our products comply with EU safe excipient level guidelines, reassuring our patients and healthcare professionals of their quality.
Rosemont are committed to the pursuit of excellence in everything that we do and therefore strive to uphold the highest quality standards. We adhere to Good Manufacturing Practice (GMP) and International Conference on Harmonisation (ICH) Q10 quality control guideline. Our manufacturing facilities are also regularly inspected and approved by both the UK and US pharmaceutical regulatory agencies. Additional approvals come from the many healthcare institutions, customers & companies purchasing Rosemont liquids worldwide.
Please email us at firstname.lastname@example.org for more information.